Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 9
2015 49
2016 51
2017 87
2018 93
2019 90
2020 50
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

359 results
Results by year
Filters applied: . Clear all
Page 1
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO; American Society of Clinical Oncology. Smith TJ, et al. J Clin Oncol. 2015 Oct 1;33(28):3199-212. doi: 10.1200/JCO.2015.62.3488. Epub 2015 Jul 13. J Clin Oncol. 2015. PMID: 26169616 Review.
The evolution of value with filgrastim in oncology.
Cornes P, Krendyukov A. Cornes P, et al. Future Oncol. 2019 May;15(13):1525-1533. doi: 10.2217/fon-2018-0762. Epub 2019 Mar 5. Future Oncol. 2019. PMID: 30835142 Free article. Review.
Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy.
Blackwell K, Semiglazov V, Krasnozhon D, Davidenko I, Nelyubina L, Nakov R, Stiegler G, Singh P, Schwebig A, Kramer S, Harbeck N. Blackwell K, et al. Ann Oncol. 2015 Sep;26(9):1948-1953. doi: 10.1093/annonc/mdv281. Epub 2015 Jun 28. Ann Oncol. 2015. PMID: 26122726 Free PMC article. Clinical Trial.
Zarxio--a filgrastim biosimilar.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2016 Mar 14;58(1490):34-5. Med Lett Drugs Ther. 2016. PMID: 26963154 Review. No abstract available.
Filgrastim induced thrombocytopenia.
Kango G, Haroun F. Kango G, et al. BMJ Case Rep. 2020 Jun 30;13(6):e234584. doi: 10.1136/bcr-2020-234584. BMJ Case Rep. 2020. PMID: 32606115
A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer.
Clemons M, Fergusson D, Simos D, Mates M, Robinson A, Califaretti N, Zibdawi L, Bahl M, Raphael J, Ibrahim MFK, Fernandes R, Pitre L, Aseyev O, Stober C, Vandermeer L, Saunders D, Hutton B, Mallick R, Pond GR, Awan A, Hilton J. Clemons M, et al. Ann Oncol. 2020 Jul;31(7):951-957. doi: 10.1016/j.annonc.2020.04.005. Epub 2020 Apr 20. Ann Oncol. 2020. PMID: 32325257 Free article. Clinical Trial.
359 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page